Close
  • All
  • Centres
  • Courses
  • Events
  • News
  • People
  • Projects

Publications

BANKE-THOMAS, A; AVOKA, CK-O; Gwacham-Anisiobi, U; Omololu, O; Balogun, M; Wright, K; Fasesin, TT; Olusi, A; Afolabi, BB; Ameh, C;
2022
BMJ global health, (2022).7 4 10.1136/bmjgh-2022-008604.
Olamiju, F; Isiyaku, S; Olobio, N; Mogaji, H; Achu, I; Muhammad, N; Boyd, S; Bakhtiari, A; Ebenezer, A; Jimenez, C; Solomon, AW; HARDING-ESCH, EM; Mpyet, CD;
2022
Ophthalmic epidemiology, (2022).30 6 10.1080/09286586.2022.2045025.
Van der Velden, FJ S; De Vries, G; Martin, A; Lim, E; Von Both, U; Kolberg, L; Carrol, ED; Khanijau, A; Herberg, JA; De, T; Galassini, R; Kuijpers, TW; Martinón-Torres, F; Rivero-Calle, I; Vermont, CL; Hagedoorn, NN; Pokorn, M; Pollard, AJ; Schlapbach, LJ; Tsolia, M; Elefhteriou, I; YEUNG, S; Zavadska, D; Fink, C; Voice, M; ... PERFORM consortium,
2022
European journal of pediatrics, (2022).182 2 10.1007/s00431-022-04642-1.
ISMAIL, SA; BELL, S; Chalabi, Z; Fouad, FM; Mechler, R; Tomoaia-Cotisel, A; Blanchet, K; BORGHI, J;
2022
Wellcome open research, (2022).7, 10.12688/wellcomeopenres.17834.1.
Chimukuche, RS; Ngwenya, N; SEELEY, J; Nxumalo, PS; Nxumalo, ZP; Godongwana, M; Radebe, N; Myburgh, N; Adedini, SA; Cutland, C;
2022
Vaccines, (2022).10 3 10.3390/vaccines10030415.
Evidence for One Dose HPV Vaccine - The DoRIS clinical trial, Tanzania.
WATSON-JONES, D;
2022
(2022).
Prevalence of curable sexually transmitted and reproductive tract infections among pregnant women attending antenatal care in Nchelenge, Zambia.
CHAPONDA, M; Chaponda, E; Mwanza, S; Chikwanda, E; Hachizovu, S; Nambozi, M; Gwasupika, J; Daka, V; Ghilardi, L; Bruce, J; CHANDRAMOHAN, D; CHICO, RM;
2022
(2022).
FILTEAU, S; Kasonka, L; Wells, JC K; Munthali, G; Chisenga, M; REHMAN, AM;
2022
British Journal of Nutrition, (2022).129 4 10.1017/S0007114522001775.
Safety of the Ad26.ZEBOV/MVA-BN-Filo vaccine regimen in adults, children and pregnant women in DRC and immunogenicity of a delayed 2nd dose: the DRC-EB-001 trial.
WATSON-JONES, D;
2022
(2022).